Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/74407
Título: Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib
Autores/as: de Vos, J.
Ramos Vega, Sara
Noorman, E.
de Vos, P.
Clasificación UNESCO: 310907 Patología
320713 Oncología
Palabras clave: Para-Nasal Sinuses
Radiation-Therapy
Paranasal Sinuses
Neck-Cancer
Head, et al.
Fecha de publicación: 2012
Publicación seriada: Veterinary and Comparative Oncology 
Resumen: In human medicine, primary frontal sinus squamous cell carcinoma (pFS-SCC) is not frequently reported. In veterinary medicine, frontal sinus SCC is exclusively described as an extension of nasal cavity SCC. To our knowledge, this is the first publication concerning canine pFS-SCC, diagnosed using histology or cytology and medical imaging, in three dogs. The tumours extended into the orbit or brain cavity, without nasal involvement. Treatment was initiated with piroxicamcarboplatin. Prolongation of carboplatin delivery with a low dose intensity was performed on dogs with a favourable initial response. Dog 1 achieved a complete remission (CR), but was euthanized 344 days after start of therapy. Dog 2, still alive 3 years after start of therapy and in CR, received 14 carboplatin deliveries. In dog 3, after changing the treatment protocol into piroxicamtoceranib, a significant tumour reduction occurred, but the dog was euthanized after 195 days because of a relapse.
URI: http://hdl.handle.net/10553/74407
ISSN: 1476-5810
DOI: 10.1111/j.1476-5829.2011.00292.x
Fuente: Veterinary And Comparative Oncology [ISSN 1476-5810], v. 10 (3), p. 206-213, (Septiembre 2012)
Colección:Artículos
Vista completa

Citas SCOPUSTM   

23
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

16
actualizado el 17-nov-2024

Visitas

162
actualizado el 27-ene-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.